Over 18 years of combined litigation experience in the US and China, Eugene can help you navigate complexities of China-related disputes. With a deep understanding of the Chinese regulatory and business environments, he helps Western clients proactively confront problems you face when doing business in China. Eugene focuses primarily on internal investigations, local and international anti-corruption enforcement actions, product liability/product quality disputes, and complex commercial disputes.
For Chinese companies involved in international disputes, he serves as a valuable advocate and guide to prevailing in a foreign legal regime. He has been on the ground in mainland China since 2007. As part of his compliance practice, he helps Western companies design and test rigorous anti-corruption policies and procedures with a business-minded approach. He conducts internal corporate investigations in native language, and regularly meets with regulatory bodies in the US and China that are conducting enforcement actions against clients.
Alongside our corporate practice, Eugene conducts anti-bribery due diligence to help you avoid further problems in China. He also works closely with our international products practice, advising on product liability and product recall matters in China. As a former food and drug attorney, he has particular knowledge of issues facing life sciences companies, from commercial bribery investigations to product liability cases involving clinical trials and serious adverse reactions.
'[H]is familiarity with both the US and PRC legal markets makes him 'an almost unique resource when it comes to dealing with FCPA issues and other US regulatory issues.''
'He is greatly experienced in representing Asian and Western companies in product liability disputes. Peers are consistently impressed by his knowledge and expertise in the field.'
Conducting compliance investigations in China for a U.S. pharmaceutical company.
Advising a major U.S. corporation on the FCPA implications of business activities in Asia.
Representing a Mexican corporation in a breach of contract lawsuit in China.
Advising a US pharmaceutical company on China compliance and labour issues related to whistleblower claims.
Representing a European pharmaceutical company in Chinese product liability lawsuits.
Assisting a European pharmaceutical company and its global insurer in handling serious adverse events in China.
Defending a U.S. pharmaceutical company in state attorney general investigations into consumer fraud and unfair competition.
Representing pharmaceutical manufacturers in nationwide class action lawsuits in the U.S. related to various drug products.
Representing a Japanese company in a multi-million dollar breach of contract arbitration before the Singapore International Arbitration Commission.
Representing a European corporation in a breach of fiduciary duty case in Singapore.
Obtaining a successful settlement of a consumer class action claim related to allegations of defective handheld devices.
Obtaining a dismissal of a consumer class action claim against a major U.S. computer manufacturer, and successfully defending the dismissal on appeal.
Representing a South Korean client in a multi-million dollar construction defect arbitration before the American Arbitration Association.
Latest thinking and events
22 November 2016
Hogan Lovells Events
28 September 2016